Lloyd Costello
Family Medicine · Highland, CANPI 1922059831
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,846 and has fallen 98.9% since, to $20 in 2025.
Across 192 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$370
- Johnson & Johnson$274
- Daiichi Sankyo Inc.$258
- AbbVie$246
- Sanofi-aventis U.S. LLC$238
- Collegium Pharmaceutical, Inc.$216
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,81599%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $370 |
| Johnson & Johnson | 16 | $274 |
| Daiichi Sankyo Inc. | 30 | $258 |
| AbbVie(2 entities) | 13 | $246 |
| Sanofi-aventis U.S. LLC | 19 | $238 |
| Collegium Pharmaceutical, Inc. | 20 | $216 |
| Amarin Pharma, Inc. | 7 | $150 |
| Pfizer | 16 | $149 |
| Vertiflex, Inc. | 1 | $125 |
| Lilly USA, LLC | 5 | $95 |
| Fidia Pharma USA Inc. | 5 | $84 |
| Novo Nordisk | 3 | $68 |
| Antares Pharma, Inc. | 3 | $68 |
| Endo Pharmaceuticals Inc. | 3 | $49 |
| Kaleo, Inc. | 3 | $47 |
| Merck | 3 | $46 |
| Biohaven Pharmaceuticals, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| SK Life Science, Inc. | 2 | $38 |
| Arbor Pharmaceuticals, Inc. | 2 | $35 |
| Biogen | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Mimedx Group, Inc. | 1 | $20 |
| AstraZeneca | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Sentynl Therapeutics, Inc. | 1 | $18 |
| UCB, Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$125
- Superion ISS$125
How this compares
$2,855 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.
Other family medicine in Highland
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.